S55746 is a Novel Orally Active BCL-2 Selective and Potent Inhibitor That Impairs Haematological Tumour Growth
Casara, P. et al., Oncotarget 2018, 9, 20075–20088
< Back to all newsCasara, P. et al., Oncotarget 2018, 9, 20075–20088
< Back to all news